Trial · NCT02639650
Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
NCT02639650, Phase 3, Unknown, Weiguo Lv
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor. Trials, record NCT02639650. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT02639650
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Study of Paclitaxel Plus Cisplatin as the First-line Chemotherapy in High Risk Gestational Trophoblastic Tumor
- NCT number
- NCT02639650
- Status
- Unknown
- Phases
- Phase 3
- Enrollment
- 214 participants, estimated
- Lead sponsor
- Weiguo Lv
- Conditions
- Gestational Trophoblastic Neoplasms
- Interventions
- Etoposide, actinomycin D, methotrexate, vincristine, cyclophosphamide, Paclitaxel, Cisplatin, Carboplatin
- First posted
- 2015-12-24
- Last updated
- 2022-06-03
Source ClinicalTrials.gov
Registered outcomes5
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | complete remission rate in firstline treatment | 3 years | We may calculate the rate of complete response and the rate of treatment failure at the preliminary end point of the trail. |
| Secondary | Severity of adverse events as assessed by the WHO | 3 years | We calculate the adverse events during and after chemotherapy. |
| Secondary | Overall Survival Rate (OR) | 3 years | We calculate the overall survival rate of high risk GTN patients after chemotherapy. |
| Secondary | Ovarian functional evaluation | every 6 months up to 3 years | We may test serum level of anti-mullerian hormone (AMH) every 6 months and the time of menstrual cycle resuming after chemotherapy. |
| Secondary | The pregnancy rate | 3 years | To calculate the pregnancy rate in an actuarial manner using the Kaplan-Meier method at the end of the trail |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT02639650
GET https://conductscience.org/api/trials/v1/NCT02639650/registered